Médecins pour Astrocytome à l'étranger — Page 2

Le Dr Felix Bokstein dirige la clinique de neuro-oncologie d'Ichilov, l'un des hôpitaux les plus grands et les plus avancés d'Israël, spécialisé dans les tumeurs cérébrales.

• Son activité principale porte sur le traitement des tumeurs complexes du cerveau et de la moelle épinière.
• En tant que chef de clinique, il supervise une unité dédiée à la neuro-oncologie.
• Son expérience inclut la prise en charge des gliomes, des astrocytomes et d'autres tumeurs malignes du SNC.
• Il intègre la chimiothérapie, les thérapies ciblées et les options d'essais cliniques dans les protocoles de soins.

Le professeur Zvi Ram dirige l'Association européenne des sociétés de neurochirurgie (EANS) – un rôle de haut niveau qui souligne son leadership dans le domaine.

• Se spécialiser dans la chirurgie mini-invasive et les techniques de cartographie cérébrale
• Être expert en opérations neurochirurgicales, y compris la stimulation cérébrale profonde (SCP)
• Pratiquer la neurochirurgie guidée par l'image pour les tumeurs cérébrales, formé en Grèce et en Suisse
• Diriger la recherche sur les thérapies géniques pour le cancer du cerveau
• Être honoré par le prix Borenstein de la Brain & Behavior Research Foundation

Le Dr Yildiz a beaucoup publié sur les tumeurs neuroendocrines et les cas oncologiques rares, ses recherches ayant été présentées dans des revues médicales internationales.

• Se spécialiser dans les tumeurs neuroendocrines et les présentations de cancers rares
• Publier plus de 17 articles évalués par des pairs sur des sujets oncologiques
• Travailler à l'hôpital universitaire Medipol Mega

Le professeur Wolfgang Köstler se spécialise dans les thérapies ciblées contre le cancer, en se concentrant sur les tumeurs mammaires et gynécologiques à la Wiener Privatklinik.

• Plus de 20 ans d'expérience en oncologie médicale
• Expert en développement de biomarqueurs et en biologie tumorale
• Professeur associé à l'Université de médecine de Vienne
• Chef adjoint de la division clinique d'oncologie

Médecin-chef dans un centre d'oncologie interdisciplinaire certifié - le Dr Viola Fox est spécialisée dans les traitements avancés de l'astrocytome.

• Experte en chimiothérapie, immunothérapie et thérapie ciblée
• Spécialiste qualifiée en génétique avec une expertise en diagnostic moléculaire
• Active dans la recherche en biologie moléculaire pour des traitements innovants contre le cancer
• Membre des sociétés d'oncologie allemandes et américaines

Le professeur associé Tahsin Ozatli est spécialisé dans les cancers du sein, du poumon et gastro-intestinaux à l'hôpital universitaire Istinye Liv.

• Spécialiste en médecine interne avec une vaste expérience en oncologie
• En exercice à la clinique d'oncologie d'Ankara et à l'hôpital régional de formation d'Erzurum
• Diplômé de la faculté de médecine de l'université de Selcuk
• Promu professeur associé en 2016

Le professeur Keil est spécialisé dans l'imagerie avancée et les interventions pour l'astrocytome au centre médical de Solingen.

• Plus de 16 ans d'expérience en radiologie diagnostique et interventionnelle
• Formé sous la direction de la célèbre radiologue, le professeur Christiane K. Kuhl
• Expert en IRM, scanner et interventions guidées par échographie
• Actuel médecin-chef de radiologie diagnostique et interventionnelle

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Le professeur associé Nail Paksoy apporte une vaste expertise en oncologie médicale, se spécialisant dans les traitements de l'astrocytome à l'Université Medipol d'Istanbul.

• Certifié par l'ESMO en oncologie médicale
• Participant actif à des essais cliniques internationaux pour les traitements du cancer
• Publier de nombreux articles de recherche sur les thérapies oncologiques innovantes

Spécialisé dans l'astrocytome et formé dans les meilleures institutions médicales turques – le Dr Alemdar apporte des soins oncologiques fondés sur des données probantes au complexe hospitalier Medical Park Antalya.

• Avoir suivi une formation en oncologie médicale à l'université d'Akdeniz
• Plus de 14 ans de traitement du cancer en milieu hospitalier et universitaire
• Vaste expérience dans des hôpitaux de formation et de recherche
• Collaborer avec des équipes multidisciplinaires pour un traitement complet

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Définition des premiers critères stricts pour le diagnostic des syndromes neurologiques paranéoplasiques – une avancée majeure en neuro-oncologie. Le Dr Graus est chercheur émérite à l'IDIBAPS.

• Ancien chef du service de neurologie à l'Hospital Clínic de Barcelone
• Fondateur et ancien président de l'Association Européenne de Neuro-Oncologie
• Doctorat de l'Universitat Autònoma de Barcelona
• Spécialisation dans les gliomes et les lymphomes cérébraux primitifs

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.